Dana-Farber Cancer Insitute at Londonderry Hospital — Londonderry, New Hampshire

Dana-Farber Cancer Insitute at Londonderry Hospital is a clinical research site located in Londonderry, New Hampshire, United States 03053.

Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Dana-Farber Cancer Insitute at Londonderry Hospital has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma.

Sponsors: Dana-Farber Cancer Institute.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Londonderry

Browse all research sites in New Hampshire · View every site in Londonderry

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber Cancer Insitute at Londonderry Hospital?

Dana-Farber Cancer Insitute at Londonderry Hospital has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber Cancer Insitute at Londonderry Hospital conducted?

Dana-Farber Cancer Insitute at Londonderry Hospital has 4 clinical trials on record, with 3 currently active. Their work covers Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma.

Is Dana-Farber Cancer Insitute at Londonderry Hospital accredited by Crixeo Clinical Trials?

Dana-Farber Cancer Insitute at Londonderry Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber Cancer Insitute at Londonderry Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.